FR2328477A1 - MEDICINAL PRODUCT FOR THE TREATMENT OF MUCOUS DISEASES, IN PARTICULAR PERIODONTAL DISEASES - Google Patents

MEDICINAL PRODUCT FOR THE TREATMENT OF MUCOUS DISEASES, IN PARTICULAR PERIODONTAL DISEASES

Info

Publication number
FR2328477A1
FR2328477A1 FR7631938A FR7631938A FR2328477A1 FR 2328477 A1 FR2328477 A1 FR 2328477A1 FR 7631938 A FR7631938 A FR 7631938A FR 7631938 A FR7631938 A FR 7631938A FR 2328477 A1 FR2328477 A1 FR 2328477A1
Authority
FR
France
Prior art keywords
diseases
treatment
mucous
medicinal product
particular periodontal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7631938A
Other languages
French (fr)
Other versions
FR2328477B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ICN Switzerland AG
Original Assignee
Solco Basel AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solco Basel AG filed Critical Solco Basel AG
Publication of FR2328477A1 publication Critical patent/FR2328477A1/en
Application granted granted Critical
Publication of FR2328477B1 publication Critical patent/FR2328477B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
FR7631938A 1975-10-24 1976-10-22 MEDICINAL PRODUCT FOR THE TREATMENT OF MUCOUS DISEASES, IN PARTICULAR PERIODONTAL DISEASES Granted FR2328477A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2547690A DE2547690B1 (en) 1975-10-24 1975-10-24 Medicines for the treatment of affections of the mucous membranes, especially periodontal diseases

Publications (2)

Publication Number Publication Date
FR2328477A1 true FR2328477A1 (en) 1977-05-20
FR2328477B1 FR2328477B1 (en) 1980-04-30

Family

ID=5960036

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7631938A Granted FR2328477A1 (en) 1975-10-24 1976-10-22 MEDICINAL PRODUCT FOR THE TREATMENT OF MUCOUS DISEASES, IN PARTICULAR PERIODONTAL DISEASES

Country Status (6)

Country Link
JP (1) JPS5270009A (en)
BE (1) BE847587A (en)
DE (1) DE2547690B1 (en)
FR (1) FR2328477A1 (en)
GB (1) GB1553088A (en)
NL (1) NL7611708A (en)

Also Published As

Publication number Publication date
JPS5270009A (en) 1977-06-10
DE2547690B1 (en) 1977-02-10
GB1553088A (en) 1979-09-19
NL7611708A (en) 1977-04-26
FR2328477B1 (en) 1980-04-30
BE847587A (en) 1977-04-22

Similar Documents

Publication Publication Date Title
FR2348201A1 (en) NEW DRUGS FOR THE TREATMENT OF ISCHEMIC VASCULAR DISORDERS
HUP9903906A2 (en) Use of chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
BE876157Q (en) ACNE TREATMENT MEDICINE
FR2313080A1 (en) TOPICAL COMPOSITION FOR THERAPEUTIC AND COSMETIC TREATMENT AND PROCESS FOR PREPARATION
DE3062981D1 (en) Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives
BE837662A (en) GELIFIED COMPOSITION CONTAINING TRETINOINE FOR THE TREATMENT OF ACNE
FR2510889B1 (en) MEDICINE CONTAINING CERTAIN RIBOFURANNOSYL-3 ', 5'-CYCLIC PHOSPHATES SUBSTITUTED IN 6, 8 FOR THE TREATMENT OF PROLIFERATIVE SKIN DISEASES
BE778334A (en) IMPROVEMENTS IN THE TREATMENT OF SKIN AND MUCOUS DISEASES
FR2341315A1 (en) MEDICINES FOR THE TREATMENT OF NEUROPATHIES
BE891987A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ORAL CAVITY DISEASES
FR2310769A1 (en) MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA SEBORRHOEICA
GR3020575T3 (en) New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions
BE854137A (en) PHARMACEUTICAL COMPOSITION OF ACNE TREATMENT
FR2311553A1 (en) MEDICINE FOR THE TREATMENT OF SCHIZOPHRENIA
BE847587A (en) MEDICINAL PRODUCT FOR THE TREATMENT OF MUCOUS DISEASES, IN PARTICULAR PERIODONTAL DISEASES
BE771357A (en) COMPOSITION FOR THE BACTERICIDAL TREATMENT OF ISOLATED AREAS OF HUMAN SKIN AND FOR THE TREATMENT OF SKIN AFFECTIONS.
BE809831A (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING SKIN DISEASES
BE809832A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES
BE837294A (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CIRCULATION DISORDERS
FR2310767A1 (en) MEDICINE FOR THE TREATMENT OF ALOPECIA CHRONICA DIFFUSA
FR2310768A1 (en) MEDICINE FOR THE TREATMENT OF ALOPECIA SENILIS
FR2673105B1 (en) NOVEL PHARMACEUTICAL COMPOSITIONS, ESPECIALLY FOR THE TREATMENT OF FUNCTIONAL COLOPATHIES, AND METHODS OF PREPARING COMPOSITIONS AND MEDICAMENTS, ESPECIALLY FOR THE TREATMENT OF THESE CONDITIONS.
FR2355508B1 (en) MEDICINAL PRODUCT FOR THE PREVENTION AND TREATMENT OF DENTAL CARIES AND PERIODONTOPATHIES AND ITS PREPARATION METHOD
FR2296430A1 (en) NEW PHARMACEUTICAL PREPARATIONS INTENDED FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF HEART CORONARY DISEASES
BE865891A (en) NEW PHARMACEUTICAL COMPOSITIONS INTENDED IN PARTICULAR FOR THE TREATMENT OF CEREBRAL FUNCTIONAL DISORDERS

Legal Events

Date Code Title Description
ST Notification of lapse